SES
8.6.2020 08:52:12 CEST | Business Wire | Press release
Local residents, businesses, government entities and the San Rafael de Leticia Hospital in the Colombian Amazonas are experiencing efficient, reliable and high-performing Internet connectivity as Colombian services provider SkyNet and SES Networks extended their partnership and increased network capacity within days to support COVID-19 mitigation efforts. SkyNet leveraged SES Networks’ Signature Solutions to deliver connectivity services to the Colombian region with the highest COVID-19 infection rate and lowest internet penetration in the country, SES announced today.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200607005067/en/
The Colombian Ministry of Telecommunications (MinTIC) selected SkyNet to install, operate and maintain five free Wi-Fi hotspots in Leticia to connect residents, as well as a high -speed dedicated broadband service for the local hospital’s medical and administrative teams to carry out telemedicine sessions and other eHealth activities to effectively respond to the crisis. These services are enabled by SES’s unique low-latency high-throughput O3b medium earth orbit (MEO) satellite constellation , which delivers fibre-equivalent performance to support high-performance data networks and solutions – including cloud services and applications.
According to the MinTIC, the enhanced broadband connectivity service allows local medical staff to communicate with other health professionals in Colombia’s capital Bogotá or institutions around the world. They benefit from tele-consultation services, collaboration with remote teams for faster speed to diagnosis, treatments and follow-ups for patients in the area.
SkyNet has been leveraging SES’s O3b MEO services since 2015 to connect remote Colombian regions, when they first delivered high-speed internet access and fibre-like services in Leticia empowering the local community, businesses and tourism industry. Today, SkyNet has become the incumbent provider in the area delivering reliable connectivity services to hundreds of households and businesses in Leticia, while also enabling access to e-learning platforms for a significant number of local students who cannot travel to attend classes due to the impact of COVID-19.
Additionally, SkyNet is now also leveraging the geostationary SES-14 satellite to enable one Wi-Fi zone for residents, local business and the municipal mayor´s office in Puerto Nariño. This Wi-Fi zone is the local residents’ only way to connect to the Internet as their 2G mobile coverage does not support mobile broadband connectivity.
“Our responsibility and commitment is to have a Colombia that is Naturally Connected. We return to our project in the Amazonas where since 2015 we have linked Leticia’s population to the world helping promote tourism, the main source of income for its inhabitants,” said Diego Moreno Lugo CEO of SkyNet of Colombia. “Today, information and communication technologies bring access to education, remote work and even telemedicine, and it is evident that with the health crisis of COVID-19, remote Colombian regions are worst-hit due to the lack of connectivity. The O3b service experience we are giving is very close to fibre optics and it is the best answer in satellite technology today. It brings great social impact, since it expands opportunities for education and health, and it has been without a doubt a great advancement for this entire community. As a company, we are proud to connect those sometimes-forgotten places.”
“The COVID-19 crisis has impacted us all and we’re committed to doing our part to support our customers and the local communities they serve wherever possible,” said Omar Trujillo, Vice President of Sales for Fixed Data Americas at SES Networks. “By enabling SkyNet to deliver reliable, high-speed broadband connectivity to historically underserved communities, businesses and healthcare workers in the Amazon region when they need it most is extremely gratifying. We are glad that our services are keeping loved ones connected and enabling healthcare workers with tools that empower them to do their job.”
Follow us on:
Social Media
Blog
Media Library
About SES
SES has a bold vision to deliver amazing experiences everywhere on earth by distributing the highest quality video content and providing seamless connectivity around the world. As the leader in global content connectivity solutions, SES operates the world’s only multi-orbit constellation of satellites with the unique combination of global coverage and high performance, including the commercially-proven, low-latency Medium Earth Orbit O3b system. By leveraging a vast and intelligent, cloud-enabled network, SES is able to deliver high-quality connectivity solutions anywhere on land, at sea or in the air, and is a trusted partner to the world’s leading telecommunications companies, mobile network operators, governments, connectivity and cloud service providers, broadcasters, video platform operators and content owners. SES’s video network carries over 8,300 channels and has an unparalleled reach of 367 million households, delivering managed media services for both linear and non-linear content. The company is listed on Paris and Luxembourg stock exchanges (Ticker: SESG). Further information is available at: www.ses.com .
About SkyNet de Colombia
SkyNet is a Colombian company with more than 20 years in the satellite telecommunications market. SkyNet creates solutions that help customers grow, even in the most remote places in the country; enabling them with the widest spectrum of satellite solutions, based on its own technology and also on services from world-leading providers.
By 2020 SkyNet has established as a priority to have a country where everyone is 'Naturally Connected', consolidating its portfolio with the development of the different Bands of services, an electromagnetic spectrum frequency used in satellite communications that implements more capacity, better coverage and affordable prices. More information: https://www.sky.net.co/
View source version on businesswire.com: https://www.businesswire.com/news/home/20200607005067/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release
FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 16:13:00 CEST | Press release
In a head-to-head benchmark, a leading general-purpose LLM was confidently wrong 35% of the time on regulatory dates. Archer Evolv™ shipped zero errors. For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and mo
Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 16:08:00 CEST | Press release
Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d
Interactive Brokers Expands Access to Korean Equities with Launch of Nextrade ATS30.6.2026 16:00:00 CEST | Press release
IB SmartRouting℠ Routes Orders to the Best Available Price Between KRX and Nextrade Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced the launch of select Korean equities through Nextrade, South Korea's first Alternative Trading System (ATS). The addition of Nextrade builds on Interactive Brokers' earlier launch of the Korea Exchange (KRX), through which it became the first major US-based broker to provide global investors with direct access to Korean equities. Clients trading on Nextrade benefit from significantly extended trading hours and access to additional liquidity. Interactive Brokers has enabled IB SmartRouting℠ across both the Korea Exchange (KRX) and Nextrade, automatically routing orders to the venue offering the best price. This helps clients achieve best execution while providing greater flexibility and more opportunities to participate in one of Asia's most dynamic equity markets. Korea's equity market ranks among the top global exchanges by
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom